Circa Group AS

Circa Group AS Dettes/EBITDA

Delisted

Ratio de la Dette Totale sur EBITDA de Circa Group AS (CIRCA.OL) au 23 oct. 2026.

Dettes/EBITDA

0,00

Dernière mise à jour:

Ratio de la Dette Totale sur EBITDA de Circa Group AS est 2023 0,00 . Ratio de la Dette Totale sur EBITDA de Circa Group AS était 2022 0,00 . Elle diminue ainsi de % plus faible par rapport à l'année précédente.

L'histoire de Circa Group AS Dettes/EBITDA

  • 3 ans

  • 10 ans

  • 25 ans

  • Max

Dettes/EBITDA
Date
Dettes/EBITDA
1 janv. 2020
0,00 EUR
1 janv. 2021
-0,00 EUR
1 janv. 2022
0,00 EUR
1 janv. 2023
0,00 EUR
L'histoire de Circa Group AS Dettes/EBITDA
ANNÉEDettes/EBITDAYoY
0,00—
0,00-100,00%
-0,00—
0,00—

Accéder à ces données via l’API Eulerpool

100 000 requêtes/mois gratuites · sans carte bancaire

Circa Group AS Analyse d'actions

Que fait Circa Group AS ? Circa Group AS produces biochemicals through its proprietary Furacell process, converting biomass into advanced bio-based chemicals. The company's product portfolio includes Cyrene, a bio-solvent derived from Levoglucosenone (LGO), which serves as a greener alternative to traditional toxic solvents in paints, coatings, battery, and textile applications. The company develops flavorings, biopolymers, and bio-solvents under development, with Cyrene being a key product for industrial processes requiring safer solvents. Subsidiaries such as Circa Sustainable Chemicals Pty Ltd, Circa Sustainable Chemicals SAS, Circa Sustainable Chemicals BV, and Circa Group Pty. Ltd. support the company's global operations. Circa Group AS sells its biochemical products primarily to industries requiring sustainable chemical solutions, including paint and coating manufacturers, battery producers, and textile companies. The company's focus on eco-friendly solvents like Cyrene targets markets seeking safer alternatives to conventional toxic solvents. By leveraging its Furacell process, Circa Group AS differentiates its offerings as advanced bio-based chemicals with improved environmental and performance profiles. The company's revenue streams are derived from the sale of its biochemical products, particularly Cyrene and other bio-solvents, to industrial clients across multiple sectors. Its subsidiaries facilitate regional market access and operational efficiency, supporting the commercialization of its proprietary technology. As a biotechnology firm, Circa Group AS monetizes its proprietary Furacell process by converting biomass into high-demand sustainable chemicals. Circa Group AS est l'une des entreprises les plus populaires sur Eulerpool.

Questions fréquemment posées sur l'action Circa Group AS

Sur Eulerpool, vous trouverez l'évolution historique complète de Circa Group AS de Ratio de la Dette Totale sur EBITDA depuis 2006 – avec des valeurs annuelles, des graphiques et une analyse détaillée.

Dette/EBITDA mesure la dette totale par rapport au résultat avant intérêts, impôts, amortissements et dépréciations. Elle indique le nombre d'années nécessaires pour rembourser toute la dette à partir de l'EBITDA.

Un 'bon' varie selon le secteur et le stade de l'entreprise. Sur Eulerpool, vous pouvez comparer Circa Group AS de Ratio de la Dette Totale sur EBITDA avec les pairs du secteur et la moyenne du secteur pour évaluer son attrait.

Accéder à ces données via l’API Eulerpool

100 000 requêtes/mois gratuites · sans carte bancaire

Endettement — Circa Group AS

Toutes les Métriques Clés — Circa Group AS

Croissance